U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H20F3N3O5S
Molecular Weight 471.45
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMS-641988

SMILES

CCS(=O)(=O)N[C@@H]1C[C@@]2(C)O[C@]1(C)[C@H]3[C@@H]2C(=O)N(C3=O)C4=CC=C(C#N)C(=C4)C(F)(F)F

InChI

InChIKey=HYNANJUKEMCYEQ-HIGHGGLBSA-N
InChI=1S/C20H20F3N3O5S/c1-4-32(29,30)25-13-8-18(2)14-15(19(13,3)31-18)17(28)26(16(14)27)11-6-5-10(9-24)12(7-11)20(21,22)23/h5-7,13-15,25H,4,8H2,1-3H3/t13-,14-,15+,18-,19+/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H20F3N3O5S
Molecular Weight 471.45
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Bristol-Myers Squibb developed BMS-641988 as a nonsteroidal androgen receptor antagonist for the treatment of prostate cancer. BMS-641988 participated in phase I clinical trials in patients with castration-resistant prostate cancer in Japan and in the USA. However, further information is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
2015-08-13
Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists.
2011-11-10
Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening.
2011-09-22
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.
2009-08-15

Sample Use Guides

Drug: BMS-641988 (AR#2) Tablets, Oral, 20 mg, 40 mg, 60 mg, 100 mg, once daily, 24 weeks
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:23:03 GMT 2025
Edited
by admin
on Mon Mar 31 21:23:03 GMT 2025
Record UNII
W17M53Y8IM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BMS-641988
Common Name English
ETHANESULFONAMIDE, N-((3AR,4R,5R,7R,7AS)-2-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)OCTAHYDRO-4,7-DIMETHYL-1,3-DIOXO-4,7-EPOXY-1H-ISOINDOL-5-YL)-
Preferred Name English
BMS 641988 [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
W17M53Y8IM
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
PRIMARY
NCI_THESAURUS
C62522
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
PRIMARY
CAS
1093276-09-5
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
PRIMARY
WIKIPEDIA
BMS-641988
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
PRIMARY
CAS
573738-99-5
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
PUBCHEM
24768935
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID70205969
Created by admin on Mon Mar 31 21:23:03 GMT 2025 , Edited by admin on Mon Mar 31 21:23:03 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY